Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Antipsychotic Medication Administered Without Proper Indication

Overland Park, Kansas Survey Completed on 11-17-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a resident was free from the use of an antipsychotic medication without a proper physician-documented indication. The resident in question had diagnoses of neurocognitive disorder with Lewy bodies and a cognitive communication deficit, with severely impaired cognition and a need for maximum or full staff assistance with activities of daily living. Despite these conditions, the resident was administered quetiapine, an antipsychotic, daily as ordered by the physician for a mood disorder. The care plan included a Black Box Warning for quetiapine, noting increased risk of death in elderly patients with dementia-related psychosis and that the medication was not approved for such use. The facility's policy required that psychotropic medications only be used for specific, documented conditions, and that antipsychotics generally be reserved for certain diagnoses, none of which were present in this case. Record review showed that the resident's electronic medical record and medication administration record lacked documentation of any abnormal behaviors or a written physician rationale for the use of quetiapine without an approved indication. The pharmacist had provided recommendations for the physician to indicate the reason for use, but the physician did not document a rationale. Additionally, psychiatry had not assessed the resident. These actions and omissions resulted in the use of an antipsychotic medication without proper justification, contrary to facility policy and regulatory requirements.

An unhandled error has occurred. Reload 🗙